Feeds:
Posts
Comments

Posts Tagged ‘prostate cancer progression’

NEW PROSTATE CANCER INFOLINK: A key goal of the prostate cancer research community has been the identification of markers that could help us to better identify patients at high risk for prostate cancer progression as early as possible in the disease process.

It now appears that the presence of an enzyme called HYAL-1 hyaluronidase and hyaluronic acid staining in prostatectomy specimens may be able to do this. READ MORE>

Read Full Post »

URO TODAY: Thalidomide and similar drugs are being assessed as powerful ways to inhibit tumour growth and spread once chemotherapy stopes working on advanced prostate cancer patients. READ MORE>


Read Full Post »

URO TODAY: A number of promising new drugs and treatments targeting prostate cancer progression are in clinical trials and have the potential to provide novel treatment options for advanced cancer in the near future. READ MORE>

Read Full Post »

URO TODAY: Smoking is likely to be a risk factor for prostate cancer progression and should be relevant in prostate cancer research and prevention of death. READ MORE>

Read Full Post »

JULY 31: URO TODAY: Higher levels of immune cells called CD68(+) macrophages found in patients having androgen deprivation therapy may be associated with greater risk of advanced prostate cancer, according to a study in Quebec. Patients with elevated abundance of CD56(+) Natural Killer cells had lower risk of prostate cancer progression. READ MORE>

Read Full Post »

JUNE 7: URO TODAY:  New research into vitamin E compounds suggests that increasing alpha-tocopherol (but not beta-carotene or retinol) levels in prostate cancer patients improves chances of survival.  Previous studies suggest that carotenoids and tocopherols (vitamin E compounds) may be inversely associated with prostate cancer risk, yet little is known about how they affect prostate cancer progression and survival.  READ MORE>

Read Full Post »

MAY 24: NEWS SCIENCE:  A cleaved form of galectin-3 may be a marker for prostate cancer progression, US researchers report in the April, 2009 , issue of The American Journal of Pathology. READ MORE>

Read Full Post »